Skip to Content
MilliporeSigma
All Photos(1)

Key Documents

244392

Sigma-Aldrich

3,3-Dimethyl-1-butyne

98%

Synonym(s):

tert-Butylacetylene

Sign Into View Organizational & Contract Pricing


About This Item

Linear Formula:
(CH3)3CC≡CH
CAS Number:
Molecular Weight:
82.14
Beilstein/REAXYS Number:
1697100
EC Number:
MDL number:
UNSPSC Code:
12352100
PubChem Substance ID:
NACRES:
NA.22

vapor pressure

7.88 psi ( 20 °C)

assay

98%

form

liquid

refractive index

n20/D 1.374 (lit.)

bp

37-38 °C (lit.)

mp

−78 °C (lit.)

density

0.667 g/mL at 25 °C (lit.)

storage temp.

2-8°C

SMILES string

CC(C)(C)C#C

InChI

1S/C6H10/c1-5-6(2,3)4/h1H,2-4H3

InChI key

PPWNCLVNXGCGAF-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

Related Categories

Application

3,3-Dimethyl-1-butyne was used in the synthesis of erythro and threo isomers of B-(3,3-dimethyl-1,2-dideuterio-1-butyl)-9-BBN by hydroboration-deuteronolysis-hydroboration sequence.

pictograms

Flame

signalword

Danger

hcodes

Hazard Classifications

Aquatic Chronic 3 - Flam. Liq. 2

Storage Class

3 - Flammable liquids

wgk_germany

WGK 2

flash_point_f

-21.1 °F

flash_point_c

-29.5 °C

ppe

Eyeshields, Faceshields, Gloves


Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Karl Matos et al.
The Journal of organic chemistry, 63(3), 461-470 (2001-10-24)
Both erythro and threo isomers of B-(3,3-dimethyl-1,2-dideuterio-1-butyl)-9-BBN (6) were prepared from 3,3-dimethyl-1-butyne (4) through a hydroboration-deuteronolysis-hydroboration sequence employing first 9-BBN-H and then 9-BBN-D, or in reverse order, respectively. Employing the Whitesides protocol, the stereochemistry of B --> Pd alkyl group
E Fontana et al.
Current drug metabolism, 6(5), 413-454 (2005-10-27)
The inhibition of human cytochrome P450s (CYPs) is one of the most common mechanisms which can lead to drug-drug interactions. The inhibition of CYPs can be reversible (competitive or non-competitive) or irreversible. Irreversible inhibition usually derives from activation of a

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service